Related Experiment Videos
Liver transplant recipient selection: MELD vs. clinical judgment
Michael A Fink1, Peter W Angus, Paul J Gow
1Liver Transplant Unit Victoria, Melbourne, Australia. mafink@unimelb.edu.au
Summary
Comparing clinical judgment with the Model for End-Stage Liver Disease (MELD) for liver transplant prioritization revealed significant differences. MELD-based allocation may reduce waiting list mortality by altering organ distribution in Australia.
Area of Science:
- Hepatology
- Transplantation Medicine
- Medical Informatics
Background:
- Accurate patient prioritization and donor liver allocation are crucial for minimizing deaths among those awaiting liver transplantation.
- Clinical judgment has traditionally guided prioritization, but objective scoring systems are increasingly utilized.
- The Liver Transplant Unit Victoria (LTUV) database provides a valuable resource for evaluating prioritization methods.
Purpose of the Study:
- To compare the effectiveness of clinical judgment versus the Model for End-Stage Liver Disease (MELD) in prioritizing patients for liver transplantation.
- To analyze the impact of MELD-based allocation on organ distribution and waiting list mortality in Australia.
Main Methods:
- Retrospective analysis of 1,118 prioritization and 263 allocation decisions from the LTUV database (August 2002 - July 2004).
- Comparison of prioritization assigned by clinical judgment with that assigned by MELD.
- Evaluation of donor liver allocation decisions based on both MELD and clinical judgment.
Main Results:
- Concordance between clinical judgment and MELD prioritization was 68% (P < 0.01).
- Donor liver allocation concordance was 72% with MELD and 77% with clinical judgment.
- Patients who died waiting were three times more likely to be prioritized by MELD (29%) than clinical judgment (9%).
Conclusions:
- An allocation process based on MELD, rather than clinical judgment alone, would significantly alter organ allocation in Australia.
- Implementing MELD-based allocation has the potential to reduce waiting list mortality for liver transplantation.